{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T14:02:43Z","timestamp":1784901763379,"version":"3.55.0"},"reference-count":22,"publisher":"FapUNIFESP (SciELO)","issue":"6","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Assoc. Med. Bras."],"abstract":"<jats:p>SUMMARY  OBJECTIVE: Rheumatoid arthritis is associated with osteoporosis and falls. While anticholinergic burden increases fracture risk in older adults, its contribution to bone health in rheumatoid arthritis is unclear. The aim of this study was to determine if anticholinergic burden is an independent risk factor for osteoporosis and fracture in rheumatoid arthritis.  METHODS: This retrospective cohort study included 120 adults with rheumatoid arthritis. Cumulative anticholinergic burden was quantified using eight validated scales (anticholinergic burden, Anticholinergic Risk Scale, Anticholinergic Drug Scale, Clinician-rated Anticholinergic Scale, Anticholinergic Activity Scale, Anticholinergic Effect on Cognition Scale, Anticholinergic Loading Scale, and CRIDECO). Outcomes included lumbar spine and hip bone mineral density, Fracture Risk Assessment Tool 10-year fracture probabilities, and World Health Organization-defined osteoporosis. Fracture Risk Assessment Tool major and L1-L4 T-score models included age, body mass index, rheumatoid arthritis duration, anticholinergic burden Calc Score, and Anticholinergic Drug Scale Score, whereas the binary osteoporosis model included age, body mass index, comorbidity count, anticholinergic burden Calc Score, and Anticholinergic Drug Scale Score.  RESULTS: In unadjusted analyses, only Clinician-rated Anticholinergic Scale \u22651 was associated with osteoporosis (p=0.010), whereas the other thresholdbased scales were not. After adjustment for the covariates specified in each model, neither anticholinergic burden Calc Score nor Anticholinergic Drug Scale Score independently predicted Fracture Risk Assessment Tool major probability (p=0.415 and p=0.189), L1\u2013L4 T-score (p=0.436 and p=0.291), or binary osteoporosis status (p=0.849 and p=0.653). Age remained the only independent predictor in the osteoporosis model (OR 1.083; 95%CI 1.019\u20131.151; p=0.010), whereas older age and lower body mass index predicted higher Fracture Risk Assessment Tool major probability.  CONCLUSION: In rheumatoid arthritis, the apparent relationship between anticholinergic burden and osteoporosis is largely explained by age, body composition, and comorbidity-related prescribing. Although anticholinergic burden was not an independent fracture risk factor after adjustment, higher anticholinergic burden may still reflect greater prescribing complexity and comorbidity burden in rheumatoid arthritis.<\/jats:p>","DOI":"10.1590\/1806-9282.20260191","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T13:14:20Z","timestamp":1784898860000},"source":"Crossref","is-referenced-by-count":0,"title":["Anticholinergic burden and bone health in rheumatoid arthritis"],"prefix":"10.1590","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1674-7216","authenticated-orcid":false,"given":"Bilal","family":"Uysal","sequence":"first","affiliation":[{"name":"Bal\u0131kesir University,  T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7460-2889","authenticated-orcid":false,"given":"Ender","family":"Salba\u015f","sequence":"additional","affiliation":[{"name":"Bal\u0131kesir University,  T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6062-6935","authenticated-orcid":false,"given":"Nilay","family":"\u015eahin","sequence":"additional","affiliation":[{"name":"Bal\u0131kesir University,  T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2026]]},"reference":[{"issue":"5","key":"ref1","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s10067-024-06932-5","article-title":"The interplay of rheumatoid arthritis and osteoporosis: exploring the pathogenesis and pharmacological approaches.","volume":"43","author":"Gupta N","year":"2024","journal-title":"Clin Rheumatol"},{"issue":"3","key":"ref2","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/BOR.0000000000000789","article-title":"Osteoporosis and fractures in rheumatoid arthritis.","volume":"33","author":"Wysham KD","year":"2021","journal-title":"Curr Opin Rheumatol"},{"issue":"4","key":"ref3","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00198-025-07397-1","article-title":"Rheumatoid arthritis and subsequent fracture risk: an individual person meta-analysis to update FRAX.","volume":"36","author":"Kanis JA","year":"2025","journal-title":"Osteoporos Int"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"152186","DOI":"10.1016\/j.semarthrit.2023.152186","article-title":"Prevalence and risk factors of falls in adults with rheumatoid arthritis: a systematic review and meta-analysis.","volume":"60","author":"Guo X","year":"2023","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s41927-023-00326-x","article-title":"Drug-related problems reported by patients with rheumatic diseases: an observational study.","volume":"7","author":"Haegens LL","year":"2023","journal-title":"BMC Rheumatol"},{"issue":"4","key":"ref6","doi-asserted-by":"crossref","first-page":"118","DOI":"10.18773\/austprescr.2022.031","article-title":"The anticholinergic burden: from research to practice.","volume":"45","author":"Hilmer SN","year":"2022","journal-title":"Aust Prescr"},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s40780-021-00213-y","article-title":"A meta-analysis of observational studies on anticholinergic burden and fracture risk: evaluation of conventional burden scales.","volume":"7","author":"Ogawa Y","year":"2021","journal-title":"J Pharm Health Care Sci"},{"issue":"12","key":"ref8","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s40266-020-00806-6","article-title":"Anticholinergic burden and fractures: a systematic review with methodological appraisal.","volume":"37","author":"Reinold J","year":"2020","journal-title":"Drugs Aging"},{"issue":"2","key":"ref9","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/bcp.12617","article-title":"Drugs with anticholinergic effects and cognitive impairment, falls and all-cause mortality in older adults: a systematic review and meta-analysis.","volume":"80","author":"Ruxton K","year":"2015","journal-title":"Br J Clin Pharmacol"},{"issue":"9","key":"ref10","doi-asserted-by":"crossref","first-page":"afad176","DOI":"10.1093\/ageing\/afad176","article-title":"Interventions for reducing anticholinergic medication burden in older adults-a systematic review and meta-analysis.","volume":"52","author":"Braithwaite E","year":"2023","journal-title":"Age Ageing"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3390\/jpm12020207","article-title":"CRIDECO anticholinergic load scale: an updated anticholinergic burden scale. comparison with the ACB scale in Spanish individuals with subjective memory complaints.","volume":"12","author":"Ramos H","year":"2022","journal-title":"J Pers Med"},{"issue":"9","key":"ref12","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2010.138461","article-title":"2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative.","volume":"69","author":"Aletaha D","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"ref13","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00198-007-0543-5","article-title":"FRAX and the assessment of fracture probability in men and women from the UK.","volume":"19","author":"Kanis JA","year":"2008","journal-title":"Osteoporos Int"},{"issue":"3","key":"ref14","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2217\/1745509X.4.3.311","article-title":"Impact of anticholinergics on the aging brain: a review and practical application.","volume":"4","author":"Boustani M","year":"2008","journal-title":"Aging Health"},{"issue":"5","key":"ref15","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1001\/archinternmed.2007.106","article-title":"The anticholinergic risk scale and anticholinergic adverse effects in older persons.","volume":"168","author":"Rudolph JL","year":"2008","journal-title":"Arch Intern Med"},{"issue":"12","key":"ref16","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1177\/0091270006292126","article-title":"The Anticholinergic Drug Scale as a measure of drug-related anticholinergic burden: associations with serum anticholinergic activity.","volume":"46","author":"Carnahan RM","year":"2006","journal-title":"J Clin Pharmacol"},{"issue":"8","key":"ref17","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1001\/archinte.161.8.1099","article-title":"Use of medications with anticholinergic effect predicts clinical severity of delirium symptoms in older medical inpatients.","volume":"161","author":"Han L","year":"2001","journal-title":"Arch Intern Med"},{"issue":"2","key":"ref18","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1136\/jnnp.2009.186239","article-title":"Use of drugs with anticholinergic effect and impact on cognition in Parkinson\u2019s disease: a cohort study.","volume":"81","author":"Ehrt U","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"ref19","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/gps.4507","article-title":"Anticholinergic effect on cognition (AEC) of drugs commonly used in older people.","volume":"32","author":"Bishara D","year":"2017","journal-title":"Int J Geriatr Psychiatry"},{"issue":"3","key":"ref20","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000325171","article-title":"Effects of anticholinergic drugs on cognitive function in older Australians: results from the AIBL study.","volume":"31","author":"Sittironnarit G","year":"2011","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"3","key":"ref21","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/jamainternmed.2014.7663","article-title":"Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study.","volume":"175","author":"Gray SL","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"5","key":"ref22","doi-asserted-by":"crossref","first-page":"105537","DOI":"10.1016\/j.jamda.2025.105537","article-title":"High anticholinergic burden of patients hospitalized for hip fracture reveals a target for deprescribing.","volume":"26","author":"McAnena AP","year":"2025","journal-title":"J Am Med Dir Assoc"}],"container-title":["Revista da Associa\u00e7\u00e3o M\u00e9dica Brasileira"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0104-42302026000602210&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T13:14:23Z","timestamp":1784898863000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0104-42302026000602210&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":22,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026]]}},"alternative-id":["S0104-42302026000602210"],"URL":"https:\/\/doi.org\/10.1590\/1806-9282.20260191","relation":{},"ISSN":["1806-9282","0104-4230"],"issn-type":[{"value":"1806-9282","type":"electronic"},{"value":"0104-4230","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"e20260191"}}